These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31075279)

  • 21. Imaging for sudden cardiac death risk stratification: Current perspective and future directions.
    van der Bijl P; Delgado V; Bax JJ
    Prog Cardiovasc Dis; 2019; 62(3):205-211. PubMed ID: 31054859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk stratification in non ischemic cardiomyopathy: a case report--Case 5/2010].
    Parade U; Klingel K; Kandolf R; Gawaz M; Schreieck J
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1122. PubMed ID: 20514634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
    Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E
    Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden death prophylaxis in heart failure.
    Rosanio S; Schwarz ER; Vitarelli A; Zarraga IG; Kunapuli S; Ware DL; Birnbaum Y; Tuero E; Uretsky BF
    Int J Cardiol; 2007 Jul; 119(3):291-6. PubMed ID: 17208319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of CMR imaging in risk stratification for sudden cardiac death.
    Aljaroudi WA; Flamm SD; Saliba W; Wilkoff BL; Kwon D
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):392-406. PubMed ID: 23473115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis.
    Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ
    Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review.
    Cevik C; Nugent K; Perez-Verdia A; Fish RD
    Clin Cardiol; 2010 May; 33(5):254-60. PubMed ID: 20513063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.
    Cavalcanti R; Aboul-Hosn N; Morales G; Abdel-Latif A
    Angiology; 2018 Apr; 69(4):297-302. PubMed ID: 28554215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use.
    Pillarisetti J; Kondur A; Alani A; Reddy M; Reddy M; Vacek J; Weiner CP; Ellerbeck E; Schreiber T; Lakkireddy D
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2831-9. PubMed ID: 24814494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
    Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
    JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiology testing for risk stratification of patients with ischaemic cardiomyopathy: a call for action.
    Katritsis DG; Zografos T; Hindricks G
    Europace; 2018 Sep; 20(FI2):f148-f152. PubMed ID: 29236981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How are European patients at risk of malignant arrhythmias or sudden cardiac death identified and informed about their risk profile: results of the European Heart Rhythm Association survey.
    Proclemer A; Bongiorni MG; Dagres N; Sciaraffia E; Todd D; Blomstrom-Lundqvist C;
    Europace; 2015 Jun; 17(6):994-8. PubMed ID: 26023178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection?
    Galand V; Martins RP; Behar N; Pichard C; Mabo P; Leclercq C
    Curr Heart Fail Rep; 2020 Aug; 17(4):116-124. PubMed ID: 32506301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy.
    Akhtar M; Elliott PM
    Curr Cardiol Rep; 2019 Nov; 21(12):155. PubMed ID: 31768884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The timing of implantable cardioverter-defibrillator implantation in patients with heart failure.
    Al-Majed NS; Ezekowitz JA
    Curr Cardiol Rep; 2012 Jun; 14(3):299-307. PubMed ID: 22426975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.
    Manolis AS
    Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):315-325. PubMed ID: 28292197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.